Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc by Rosell, Albert et al.
Structural bases for the interaction and stabilization of
the human amino acid transporter LAT2 with its
ancillary protein 4F2hc
Albert Rosella,b,1, Marcel Meuryc,d,1, Elena Álvarez-Marimona,b,1, Meritxell Costaa,b,c,d,1, Laura Pérez-Canoe,
Antonio Zorzanoa,f,g, Juan Fernández-Recioe,2, Manuel Palacína,b,f,2, and Dimitrios Fotiadisc,d,2
aInstitute for Research in Biomedicine (IRB Barcelona), E-08028 Barcelona, Spain; bCentro de Investigación Biomédica en Red de Enfermedades Raras, E-08028
Barcelona, Spain; cInstitute of Biochemistry and Molecular Medicine, and dSwiss National Centre of Competence in Research TransCure, University of Bern,
CH-3012 Bern, Switzerland; eJoint Barcelona Supercomputing Center-IRB Program in Computational Biology, Department of Life Sciences, Barcelona
Supercomputing Center, E-08034 Barcelona, Spain; fDepartment of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, E-08028
Barcelona, Spain; and gCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, E-08028 Barcelona, Spain
Edited* by Christopher Miller, Howard Hughes Medical Institute, Brandeis University, Waltham, MA, and approved January 15, 2014 (received for review
December 24, 2013)
Heteromeric amino acid transporters (HATs) are the unique ex-
ample, known in all kingdoms of life, of solute transporters
composed of two subunits linked by a conserved disulfide bridge.
In metazoans, the heavy subunit is responsible for the trafficking
of the heterodimer to the plasma membrane, and the light subunit
is the transporter. HATs are involved in human pathologies such as
amino acidurias, tumor growth and invasion, viral infection and
cocaine addiction. However structural information about interac-
tions between the heavy and light subunits of HATs is scarce. In
this work, transmission electron microscopy and single-particle
analysis of purified human 4F2hc/L-type amino acid transporter 2
(LAT2) heterodimers overexpressed in the yeast Pichia pastoris,
together with docking analysis and crosslinking experiments, re-
veal that the extracellular domain of 4F2hc interacts with LAT2,
almost completely covering the extracellular face of the trans-
porter. 4F2hc increases the stability of the light subunit LAT2 in
detergent-solubilized Pichia membranes, allowing functional re-
constitution of the heterodimer into proteoliposomes. Moreover,
the extracellular domain of 4F2hc suffices to stabilize solubilized
LAT2. The interaction of 4F2hc with LAT2 gives insights into the
structural bases for light subunit recognition and the stabilizing
role of the ancillary protein in HATs.
CD98hc | 4F2hc ectodomain
Heteromeric amino acid transporters (HATs) are composedof two subunits, a heavy (SLC3 family) and a light subunit
[SLC7 or L-type amino acid transporter (LAT) family] linked by
a conserved disulfide bridge (1). HATs are amino acid exchangers
(1), and this transport activity resides in the light subunit (2). The
heavy subunit (either 4F2hc or rBAT) is essential for trafficking of
the holotransporter to the plasma membrane (3, 4). In mammals,
six transporters heterodimerize with 4F2hc, and only one hetero-
dimerizes with rBAT. The rBAT/b0,+AT complex is a dimer of
heterodimers in which the light subunit is required for proper
rBAT folding and stability (5, 6). In contrast, 4F2hc-associated
transporters are simple heterodimers (6), and possible stabilizing
roles of the two subunits in the biogenesis of the heterodimer
have not been described.
HATs have major impacts on human health and are involved
directly in amino acidurias (cystinuria and lysinuric protein intol-
erance), tumor cell growth, glioma invasion, Kaposi’s sarcoma-
associated herpesvirus infection, and cocaine relapse (1). In
addition to the role of HATs in amino acid transport, 4F2hc
heterodimers mediate β1- and β3-integrin signaling (7).
Structural information about HATs is scarce (1). The heavy
subunits are type II membrane N-glycoproteins with a single
transmembrane domain (TMD), an intracellular N terminus,
and a large extracellular C terminus with sequence homology
with bacterial α-amylases. Indeed, the atomic structure of the
extracellular domain (ED) of human 4F2hc (4F2hc-ED) is sim-
ilar to that of bacterial glucosidases [i.e., a triose phosphate isom-
erase barrel, (βα)8, (subdomain A) and eight antiparallel β-strands
(subdomain C)] but lacks glucosidase activity (8). The con-
served cysteine residue participating in the intersubunit disul-
fide bridge is located between the single TMD and 4F2hc-ED.
Physical and functional interaction of 4F2hc with integrins has
been mapped to the TMD and cytosolic N-terminal domain
(7, 9), whereas 4F2hc-ED is necessary for functional hetero-
dimerization with the light subunit (9, 10). The light subunits are
nonglycosylated proteins and have a 12-TMD topology with in-
tracellular N and C termini (1). The conserved cysteine residue
involved in the intersubunit disulfide bridge is located between
TMD3 and TMD4 (11). Structure–function studies (12, 13)
suggest that the structures of the light subunit of HATs should
be similar to those of remote bacterial amino acid/polyamine/
organocation (APC) transporters (∼20% amino acid sequence
identities), which present the LeuT-fold (14–17). In contrast,
there is no structural information about the interaction between
the two HAT subunits. In the present study, we show that infor-
mation from transmission electron microscopy (TEM) and single-
particle analysis (SPA) of human 4F2hc/L-type amino acid
transporter 2 (LAT2) heterodimers is compatible with 4F2hc-
ED interacting with the extracellular loops of LAT2. Docking
analyses and crosslinking experiments indicated a location of
4F2hc-ED almost completely covering the external face of LAT2.
Moreover, 4F2hc increases the stability of detergent-solubilized
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LAT2, allowing functional reconstitution of the heterodimer into
proteoliposomes. The interaction of 4F2hc-ED with LAT2 pro-
vides insights regarding the structural bases for recognition of
the light subunit and the stabilization of this complex and other
4F2hc associated transporters.
Results
TEM, SPA, and 3D Reconstruction of the Human 4F2hc/LAT2 Complex.
Recombinant 4F2hc/LAT2 purified by Co2+- and Strep-Tactin
affinity chromatography (18) was analyzed by negative-stain
TEM and SPA to unveil the supramolecular architecture of
HATs (Fig. 1). On electron micrographs distinct particles cor-
responding to purified 4F2hc/LAT2 complexes are discerned as
composed of two globular domains of different sizes (Fig. 1A,
boxed particles and gallery). From 15,210 single-particle pro-
jections, class averages were calculated (Fig. S1A). Most class
averages indicate a clear difference in size between the two
domains. A few smaller particles reflecting 4F2hc or LAT2 from
disrupted heterodimers were also found on electron micrographs
(Fig. 1A, arrowheads). In addition, some small protein aggre-
gates are seen on electron micrographs (Fig. 1A, asterisks). We
determined the structure of 4F2hc/LAT2 by 3D reconstruction
from negatively stained complexes (Fig. 1B). The resolution of
the 3D map obtained from the final refinement run was 21 Å
(Fig. S1B) and had a homogeneous angular distribution of pro-
jections (Fig. S1C). The calculated 3D map reflects a structure
composed of a smaller and a larger density (Fig. 1B; see Fig. S1D
for additional views). The smaller domain lies tilted (not flat) on
the larger domain (Fig. 1B, black dotted line). Consequently, the
complex has a cleft on one side (Fig. 1B, arrowhead) and a seal
on the opposite side (Fig. 1B, white dotted curve). Importantly,
the crystal structure of 4F2hc-ED fits nicely into the smaller
density (Fig. 1C), making the assignment of 4F2hc and LAT2 in
the 3D map possible. As determined by scanning TEM mass
measurement, unstained n-dodecyl-β-D-maltoside (DDM)-puri-
fied membrane proteins prepared in a conventional way for
TEM are associated with >55 kDa of copurified endogenous
lipids and DDM molecules (19). Thus, the total mass of the
LAT2/lipid/DDM ternary complex plus the single TMD and the
cytoplasmic N-terminal domain of 4F2hc containing the His-tag
and the protease cleavage site (>120 kDa) is significantly larger
than that of the 4F2hc-ED (∼50 kDa). This result, together with
the fitting of the 4F2hc crystal structure into the smaller density,
supports the assignment of LAT2 to the larger domain of the 3D
map. In Fig. 1C the location of the N terminus in the 4F2hc-ED
crystal structure is marked by an asterisk. This location is close to
an additional density connecting the small and large domains
that possibly arises from the N-terminal TMD of 4F2hc and
extracellular loops of LAT2.
Crosslinking of 4F2hc-ED and LAT2. To confirm the interaction be-
tween 4F2hc-ED and LAT2, specific intersubunit crosslinking
between cysteine residues were assessed in purified 4F2hc/LAT2
heterodimers (Fig. 2). To this end, homogenates from HEK293T
cells transiently cotransfected with N-terminally His-tagged 4F2hc
(His-4F2hc) and N-terminally Strep-TagII–tagged LAT2 (Strep-
LAT2) were solubilized with DDM and purified by Ni2+-affinity
chromatography and then were crosslinked with the nonreducible
cysteine crosslinkers bis(maleimido)ethane (BMOE) (with a
spacer arm up to 10.5 Å) or 1,8-bis(maleimido)diethylene glycol
[BM(POE)2] (with a spacer arm up to 14.3 Å). Crosslinking
experiments were performed in mammalian cells because
mutants could be generated more conveniently in mammalian
cells than in Pichia cells. Western blotting under reducing con-
ditions and using an anti-Strep antibody revealed intersubunit
crosslinking as DTT-resistant heterodimers. Human 4F2hc has
two cysteine residues: Cys109, participating in the intersubunit
disulfide bridge (located in the “neck” connecting the TMD and
ectodomain) and Cys330, a partially hidden residue (located in
the A-subdomain of the ectodomain). To avoid doubtful results,
residue Cys330 was mutated to serine (C330S) in all mutants
studied, and residue Cys109 was maintained to hold the disulfide
intersubunit bridge. This strategy was validated by demonstrating
heterodimerization of His-4F2hc C330S with Strep-LAT2 and
induction of L-alanine transport in HEK293T cells (Fig. S2 A–D).
Fig. 1. TEM, SPA, and 3D reconstruction of human 4F2hc/LAT2. (A) Over-
view electron micrograph of purified, negatively stained 4F2hc/LAT2 heter-
odimers. The boxed 4F2hc/LAT2 complexes were magnified and are displayed
in the gallery. Arrowheads mark 4F2hc or LAT2 monomers from disrupted
heterodimers. Asterisks indicate small protein aggregates. (Scale bar: 50 nm.)
The frame sizes of the magnified particles in the gallery are 21.8 nm. (B) 3D
reconstruction of 4F2hc/LAT2 calculated from projections of negatively
stained heterodimer particles. Different side views of the 3D model are
shown. 4F2hc/LAT2 is composed of a large and a small density. The small
density is located on top of the large density and is tilted, as indicated by the
black dotted line. As indicated by an arrowhead, the 3D model features
a distinct cavity. On the opposite side, both subunits are in close contact, as
marked by the white, dotted curve. (Scale bar: 5 nm.) (C) Side (Upper) and
top (Lower) views of the 4F2hc/LAT2 3D reconstruction without and with the
fitted crystal structure of the 4F2hc-ED (Protein Data Bank ID code: 2DH2).
The fitting assigns the small and large subunits to 4F2hc and LAT2, re-
spectively. The structure of 4F2hc-ED is represented as a cartoon and surface
model. Asterisks indicate the location of the N terminus in the 4F2hc-ED
crystal structure. (Scale bar: 5 nm.)








According to our homology models of human LAT2 (Fig. S3 A
and B), which are based on the atomic structure of the bacterial
L-arginine/agmatine exchanger AdiC (17), seven of the nine en-
dogenous cysteine residues in LAT2 are located in TMDs and
internal loops (Fig. S3 A and C). The remaining two cysteine
residues are in external loops: Cys154, participating in the
intersubunit disulfide bridge, is located in the external loop
TMD3–4, and Cys210 is located in the external loop TMD5–6
(Fig. S3 A and C). Nine serine residues spread over the surface
of 4F2hc-ED potentially facing LAT2 (8) were selected and
mutated individually to cysteine for crosslinking experiments
(see locations in Fig. S2E). Five of the nine mutants were not
considered for further studies because they produced proteo-
lyzed proteins (S191C and S200C) (Fig. S2F, lanes 2 and 3) or
lacked (S270C) (Fig. S2F, lane 4) or inefficiently formed (S497C
and S506C) (Fig. S2 G and H, lanes 7 and 8) intersubunit
disulfide bridges when cotransfected with Strep-LAT2. The other
four 4F2hc mutants (S151C, S185C, S393C, and S412C), also
containing the C330S mutation, heterodimerized with Strep-
LAT2 (Fig. S2G andH, lanes 1, 3, 5, and 6) and induced L-alanine
transport similar to 4F2hc C330S (Fig. S2I). Of these four
mutants, only S151C and S412C could be crosslinked with wild-
type LAT2 using BMOE and BM(POE)2 [Fig. 2A; BMOE:
lanes 1 and 7; BM(POE)2: lanes 9 and 12]. Interestingly, cross-
linking with 4F2hc mutants S151C and S412C was totally
abolished when LAT2 Cys210 was mutated to serine (C210S) [Fig.
2A; BMOE, lanes 2 and 6; BM(POE)2, lanes 8 and 11]. The C210S
(LAT2) mutant is fully functional (i.e., heterodimerized (Fig. S2 G
andH, lanes 2 and 4) and induced L-alanine transport with 4F2hc
(Fig. S2I). In contrast, mutant C330S (Fig. 2A, lanes 5 and 10),
and mutants S185C (Fig. 2A, lane 3) and S393C (Fig. 2A, lane 4)
incorporated in this background did not show crosslinking with
Fig. 2. Crosslinking of 4F2hc/LAT2 and docking model of the 4F2hc-ED and LAT2 complex. (A and C) Intersubunit crosslinking. Versions of His-4F2hc/Strep-
LAT2 heterodimers expressed in HEK293T cells and purified by His-affinity chromatography were treated with the DTT-uncleavable crosslinkers BMOE or BM
(POE)2. Crosslinking was detected as DTT-resistant 4F2hc/LAT2 heterodimers (arrowhead) by Western blotting using αStrep antibodies under reducing con-
ditions. The band of LAT2 monomer corresponds to LAT2 forming heterodimers with 4F2hc (i.e., copurified but not crosslinked). Single cysteine mutants were
introduced in 4F2hc (C330S)/LAT2 wild-type (A) or LAT2 (C210S) (C). In all cases, crosslinking was abolished when 4F2hc (C330S) or LAT2 (C210S) was used,
indicating the specificity of the crosslinked sites. (B) Lowest-energy model of the 4F2hc-ED–LAT2 complex. Highlighted cysteine residues (endogenous or
added through mutation) are shown as sphere models (C atoms, gray; O atoms, red; N atoms, blue; S atoms, yellow). The putative N-glycosylation sites (N264,
N280, N323, and N405 indicated in purple) and the non-crosslinked residues (C185 and C393 in gray) of 4F2hc are located in the most external face. (D)
Summary of the crosslinked residues. The 4F2hc-ED–LAT2 model in B was rotated by 90°, i.e., viewed from 4F2hc-ED. Only the cysteine residues (endogenous
or added through mutation) of the 4F2hc-ED are shown as sphere models with C atoms in green. In LAT2 (cartoon in blue) the cysteine residues (endogenous
or added through mutation) are shown as sphere models with C atoms in gray. Crosslinked residues are connected by a line denoting the percentage of
crosslinking (solid red line: 80–95%; solid yellow line: ∼60%; red dotted line: 5–10%). Similarly, the intersubunit disulfide bridge between C109 (4F2hc) and
C154 (LAT2) is represented by a solid red line because it is present in >95% of the expressed LAT2 (see text for details).
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wild-type LAT2. These results demonstrated specific crosslinking
between cysteine residues at positions 151 or 412 (which are
located in the loop Aα1–Aβ2 and helix Aα8′′′, respectively) of
subdomain A of 4F2hc-ED and Cys210, which is located in the
extracellular loop TMD5–6 in LAT2.
Docking Analysis of 4F2hc-ED and LAT2. To characterize the inter-
actions between 4F2hc-ED and LAT2, protein-docking analyses
between the atomic structure of 4F2hc-ED (8) and homology
models of human LAT2 (Fig. S3B) were performed with only
two restrictions: (i) allowing the formation of the disulfide bridge
between residues Cys109 (4F2hc-ED) and Cys154 (LAT2), and
(ii) avoiding clashes between 4F2hc-ED residues and the plasma
membrane (SI Methods). Of 3,145 possible docking poses, the
model with the lowest energy is depicted in Fig. 2B. According to
this model, 4F2hc-ED interacts with all the extracellular loops or
ends of TMDs of LAT2. 4F2hc is N-glycosylated in Pichia (18)
and mammalian cells (8), and in the model the four putative sites
are located in the most external face of 4F2hc-ED, out of the
contact interface with LAT2 (Fig. 2B). There is a large in-
teraction surface between the two proteins, with the buried
surface area of LAT2 upon 4F2hc binding being 1,735 Å2 (Fig.
S4A). As much as 60% of the LAT2 interaction surface is formed
by hydrophobic residues, and 40% is formed by aromatic resi-
dues. This composition is consistent with the major contribution
of desolvation to the binding energy as calculated by our scoring
function. The most important contacting residues are shown in
Table S1 and Fig. S4B.
Interestingly, the lowest-energy 4F2hc-ED–LAT2 model com-
plies with the crosslinking analysis described above. Thus, cross-
linked residues S151C (4F2hc)–Cys210 (LAT2) and S412C
(4F2hc)–Cys210 (LAT2) were located at minimal interatomic
distances of 13.4 Å and 11.5 Å, respectively (Table S2). These
distances are in good agreement with the results obtained from
crosslinking with BMOE and BM(POE)2, in which the distances
separating both reactive maleimide ends range from 6.3 to 10.5
Å and from 3.5 to 14.3 Å, respectively (20). In contrast, the
4F2hc residues that did not crosslink, S393C and S185C, are
located at distances of 18.8 Å and 28.2 Å, respectively, from
LAT2 Cys210, also corroborating the docking model (Table S2).
Then, guided by this docking model, additional cysteine mutants
in protein domains not studied previously were considered for
crosslinking, i.e., S195C in helix 2 of subdomain A and S487C
and G505C in subdomain C of 4F2hc-ED and A235C, A315C,
G392C, and S441C in four external loops of LAT2 (Table S2).
To ascribe the crosslinked residues unequivocally, 4F2hc mutants
were generated in C330S background, and LAT2 mutants were
generated in the C210S background, taking advantage of the fact
that LAT2 C210S heterodimerized with the newly considered His-
4F2hc mutants (Fig. S5 A and B, lanes 7, 12, and 17) in HEK293T
cells. Moreover, the rest of the additional 4F2hc and LAT2
mutants heterodimerized and induced L-alanine transport in the
transfected cells (Fig. S5). Six new paired positions in 4F2hc and
LAT2 were crosslinked by BMOE and/or BM(POE)2 (Fig. 2C and
Fig. S6 A and B). Interestingly, the new pairing of G505C (4F2hc)
with A235C and S441C (LAT2) (Fig. 2C, lanes 6 and 7) and the
already mentioned pairing of S151C and S412C (4F2hc) with
Cys210 (LAT2) (Fig. 2A) crosslinked almost completely (80–95%)
(Table S2). Together with the intersubunit disulfide bridge be-
tween Cys109 (4F2hc) and Cys154 (LAT2), which links >95% of
the expressed LAT2 mutants to 4F2hc (Fig. S2G, lanes 1 and 3
and Fig. S5A, lanes 15 and 16), these results triangulate the lo-
cation of 4F2hc-ED over the external face of LAT2 (Fig. 2D).
Indeed, our crosslinking studies showed that four of the six ex-
ternal loops of LAT2 (Cys210 and Ala235 in TMD5–6, Ala315 in
TMD7–8, Gly392 in TMD9–10, and Ser441 in TMD11–12) (Fig.
S3, asterisks) are in the vicinity of residues in subdomains A
and C of the 4F2hc-ED in addition to the intersubunit disulfide
bridge connecting Cys154 in TMD3–4 of LAT2 and Cys109 lo-
cated five residues away from the C-terminal end of the 4F2hc
TMD (Fig. 2D and Table S2). According to the lowest-energy
4F2hc-ED–LAT2 model, all the crosslinked positions in the
present work are 8.1–17.5 Å apart (Table S2). In contrast, paired
positions separated by >15 Å or >18 Å were not crosslinked by
BMOE or BM(POE)2, respectively (Fig. 2A, Fig. S6A, and Table
S2). The lack of crosslinking in the indicated paired positions was
not caused by cysteine residues being blocked by the formation
of a direct disulfide bridge as the result of very close proximity
(Fig. S6 B and C). Thus, the lowest-energy docking model is in
full agreement with all crosslinking experiments. Moreover, if a
slightly larger crosslinking distance is considered, only two very
similar additional docking solutions comply with the five stron-
gest (≥60% efficiency) crosslinking experiments (Fig. S4C). Like
the 3D 4F2hc/LAT2 map from TEM and SPA, these docking
models place 4F2hc-ED tilted on top of LAT2. Unfortunately, at
the resolution of 21 Å, the large volume of the larger domain in
the map (Fig. 1C), which contains LAT2, the TMD and the N-
terminal domain of 4F2hc, lipid, and detergent, precludes a re-
liable fitting of the 4F2hc-ED–LAT2 docking model into the 3D
4F2hc/LAT2 map. In summary, TEM, SPA, docking, and cross-
linking studies strongly indicate that 4F2hc-ED is positioned tilted
on LAT2, almost completely covering the extracellular face of
the transporter.
The Ectodomain of the Heavy Subunit 4F2hc Increases the Stability of
LAT2. The interaction between 4F2hc-ED and the overall exter-
nal face of LAT2 suggests that the heavy subunit may affect the
stability of the light subunit. To investigate this possibility, we
studied the behavior of purified 4F2hc/LAT2 and LAT2. Solu-
bilization with DDM of isolated membranes from yeast cells
coexpressing His-4F2hc and Strep-LAT2 and sequential purifi-
cation by Co2+- and Strep-Tactin affinity chromatography
yielded 4F2hc/LAT2 heterodimers (18). In contrast, DDM sol-
ubilization of yeast membranes expressing Strep-LAT2 alone
and subsequent Strep-Tactin affinity chromatography and size-
exclusion chromatography yielded only aggregates of LAT2 (Fig.
3A). To study whether 4F2hc was able to conserve the func-
tionality of LAT2, we tried to reconstitute purified 4F2hc/LAT2
heterodimers into liposomes, but our attempts failed. As an al-
ternative approach to test the functionality of 4F2hc/LAT2
heterodimers and LAT2 monomers, isolated Pichia membranes
were solubilized in DDM and reconstituted into proteoliposomes.
Interestingly, only 4F2hc/LAT2 heterodimers, but not LAT2
monomers, could be reconstituted successfully into proteolipo-
somes as functional proteins (Fig. 3B), because LAT2 monomers
aggregated before being inserting into liposomes (Fig. S7A).
Surprisingly, expression of Strep-LAT2 alone, as well as coex-
pression of His-4F2hc and Strep-LAT2, resulted in a similar
transport of 10 μM L-leucine over background in P. pastoris cells
(Fig. S7B). These results suggest that LAT2 is properly folded
and trafficked to the plasma membrane in yeast cells. However,
the interactions with 4F2hc would be essential to maintain the
correct folding of the light subunit in detergent. Kinetic analysis
of L-leucine transport via His-4F2hc/Strep-LAT2 and Strep-
LAT2 revealed similar Kms: 178 ± 15 μM and 120 ± 7 μM, re-
spectively (Fig. S7C). Thus, the interaction between 4F2hc and
the extracellular surface of LAT2 increased the stability of the
detergent-solubilized light subunit but did not alter dramatically
the substrate apparent affinity of this transporter in vivo.
Next, we asked whether the ectodomain of 4F2hc is able to
stabilize LAT2 without the generation of the conserved disulfide
bridge between both HAT subunits. Pichia membranes express-
ing Strep-LAT2 were incubated with purified His-4F2hc-ED,
and then LAT2 was solubilized with different concentrations of
DDM (Fig. 4A). Interestingly, preincubation with 4F2hc-ED, but
not with same concentration of BSA, increased the solubilization
of LAT2 at the three concentrations of detergent tested (1%,
0.5%, and 0.25% DDM). These results suggested that 4F2hc-ED
stabilizes LAT2 in solution. To test this possibility, LAT2 solu-
bilized in 1% DDM in the absence or presence of 4F2hc-ED was
ultracentrifuged at 2 h, 24 h, and 72 h after solubilization. Re-
markably, the presence of 4F2hc-ED dramatically prevented the








precipitation of LAT2 (Fig. 4 B and C). In summary, these
results indicate that the ectodomain of 4F2hc interacts with the
external face of LAT2, thus increasing the stability of the de-
tergent-solubilized transporter and allowing its functional re-
constitution into proteoliposomes.
Discussion
This study reports on the supramolecular organization and the
structural bases of the interactions of the heavy and light sub-
units of HATs. Specifically, three lines of evidence (TEM, SPA,
and docking and crosslinking analyses) strongly support the no-
tion that 4F2hc-ED almost completely covers the extracellular
surface of the transporter subunit LAT2. Indeed, we identified
specific residues that crosslinked 4F2hc and LAT2 nearly com-
pletely (>80%). This crosslinking, together with the endogenous
intersubunit disulfide bridge, triangulates the position of the
4F2hc-ED over the external face of LAT2 (Fig. 2D). Impor-
tantly, the proposed docking model, as well as two additional and
highly similar poses, fulfills the steric restrictions defined by the
results from crosslinking (Fig. S4C).
Our docking analysis used the atomic structure of human
4F2hc-ED and homology models of human LAT2 based on the
atomic structure of the amino acid transporter AdiC in an out-
ward-facing conformation. Because of the low sequence con-
servation in the loops of AdiC and LAT2 (Fig. S3A), our docking
models do not represent high-resolution structures of the 4F2hc-
ED–LAT2 complex. Nevertheless, docking analysis revealed
desolvation as the main contributor to the binding energy of
4F2hc-ED and LAT2. Indeed, the LAT2 residues that are pre-
dicted to be more relevant for the interactions are mainly hy-
drophobic, and they can be grouped into two clearly defined
patches [see Normalized Interface Propensity (NIP) residues in
Table S1 and Fig. S4 A and B]. One of the patches, which is
totally hydrophobic, is composed of nine residues distributed
along three external loops or TMD ends of LAT2 (TMD3–4,
which harbors the Cys154 residue involved in the disulfide
bridge, TMD9–10, and TMD11–12). The other is a mixed patch
composed of four polar and five hydrophobic residues located in
loops TMD1–2, TMD5–6, and TMD7–8. The interaction be-
tween 4F2hc-ED and LAT2 raises the question of whether the
heavy subunit might have an impact on the LAT2 transport cycle.
The structural paradigms of HAT light subunits, the bacterial
APC transporters, present the LeuT-fold (14–17). Secondary
transporters, upon the binding of an external substrate, transit to
inward-facing conformations to release the substrate inside the
cell. Besides transporter-specific changes, atomic structures of
LeuT-fold transporters showed a commonality of features in this
transition (21, 22): the “hash” domain (TMDs 3, 4, 8, and 9) and
the extracellular ends of the “bundle” domain (TMDs 1, 2, 6, and
7) become closer, and the loop TMD7–8 occludes the external
vestibule of the transporter. Our results indicate that these
conformational changes are compatible with 4F2hc-ED directly
contacting the external loops or ends of TMDs of LAT2. The
highly conserved hydrophobic patch in LAT2 (Fig. S4B and
Table S1), together with the intersubunit disulfide bridge, glue
the hash domain and TMDs 11 and 12 to 4F2hc-ED. TMDs 11
and 12 are, according to the structural homolog AdiC (17), the
most static TMDs. In contrast, the mixed patch is less conserved
and involves the bundle domain and the occluding loop (TMD7–
8). This architecture suggests that 4F2hc/LAT2, and probably
other HATs, have evolved to bind the ectodomain of the heavy
subunit firmly to the hash domain. In this scenario, energetically
similar interactions of 4F2hc-ED with the bundle domain and
loop TMD7–8 would be broken and replaced by the different
conformations that the light subunit undergoes during the
transport cycle.
According to amino acid transporters with LeuT-fold, the
substrate-binding site in LAT2 is expected to be located at the
bottom of the extracellular vestibule (1, 13) and therefore far
away from the interacting 4F2hc-ED residues (Fig. S4 D and E).
Moreover, our docking analysis located 4F2hc-ED in a tilted
Fig. 3. (A) Size-exclusion chromatography profiles of purified 4F2hc/LAT2
(thick curve) and purified LAT2 (thin curve). 4F2hc/LAT2 elutes at 9.8 mL,
whereas LAT2 is eluted in the void volume (8 mL). (B) Time-course of L-leu-
cine uptake in 4F2hc/LAT2 and 4F2hc proteoliposomes. Transport of 10 μM
L-[3H]leucine into proteoliposomes was measured at 10, 30, 60, 90, 120, 150,
180, and 210 min and at 20 h. Proteoliposomes were loaded or not loaded
with 4 mM cold L-isoleucine. Data are mean ± SEM of a representative ex-
periment performed in triplicate. Transport of 10 μM L-[3H]leucine into
4F2hc/LAT2 proteoliposomes preloaded with 4 mM L-isoleucine resulted in
an overshoot. In contrast, L-leucine transport into 4F2hc/LAT2 proteolipo-
somes with no amino acids inside showed passive diffusion similar to that
shown by 4F2hc proteoliposomes filled or not filled with L-isoleucine. This
behavior is characteristic of coupled transporters such as the H+/lactose
cotransporter LacY (27) and exchangers such as the LAT transporter SteT, an
L-serine/L-threonine exchanger from Bacillus subtilis (28).
Fig. 4. 4F2hc-ED increases LAT2 solubility and stability. (A) Western blot
analysis of DDM-solubilized LAT2 in the presence of 1 mg/mL of 4F2hc-ED or
BSA or plain buffer, as indicated. (B) Western blot analysis of solubilized
LAT2 (1% DDM) in the presence or absence of 1 mg/mL of 4F2hc-ED at
different times. (C) Quantification of the soluble LAT2 at the indicated time.
Data are the mean ± SEM of three independent experiments as described in
B. LAT2 remaining in solution after ultracentrifugation was considered sol-
uble LAT2. LAT2 was detected using αStrep antibody. The presence of 4F2hc-
ED increased LAT2 stability at all analyzed times.
2970 | www.pnas.org/cgi/doi/10.1073/pnas.1323779111 Rosell et al.
position, with subdomain C interacting with LAT2 TMD11–12
and leaving open a window in the opposite location flanked by
LAT2 TMD7–8 for the entrance of the substrate to the binding
site (Fig. S4D). Despite the different structures of the LAT2
monomer and the 4F2hc/LAT2 heterodimer, the measured Km
values for L-leucine transport in Pichia cells were comparable,
suggesting that 4F2hc would have no significant impact on the
substrate affinity of LAT2.
The hydrophobic character of the interaction between 4F2hc-
ED and LAT2 might be the basis for the stabilization of this light
subunit by 4F2hc. We show that 4F2hc allows functional re-
constitution into proteoliposomes and purification of the trans-
porter after solubilization with DDM. Moreover, we show here
that 4F2hc-ED suffices to increase the stability of DDM-solu-
bilized LAT2. The binding of 4F2hc-ED to the extracellular
surface of LAT2 would bury a large hydrophobic patch that
otherwise would be exposed to solvent, thus reducing aggrega-
tion and increasing stability. In addition, the compact and ther-
mally stable structure (Tm ∼59 °C) (23) of 4F2hc-ED may have
additional effects in improving LAT2 stability.
HATs appeared in metazoans with an ancient heavy subunit
that evolved to differentiated 4F2hc and rBAT in vertebrates (1).
The fact that LAT2 monomers elicited amino acid transport in
Pichia cells, which do not express 4F2hc or related proteins,
indicates that 4F2hc is not required for proper folding of LAT2,
as also has been demonstrated for the light subunit b0,+AT in the
absence of rBAT (2). In contrast, 4F2hc and rBAT are necessary
for heterodimerization and functional expression of light sub-
units at the cell surface when expressed in Xenopus oocytes and
mammalian cells (1). Specifically, 4F2hc-ED is necessary for
these functions (9, 10). Desolvation of hydrophobic residues
might be extended to the recognition of other light subunits by
4F2hc. The hydrophobic NIP residues in our docking analysis are
highly conserved in 4F2hc-associated light subunits but are poorly
conserved in cyanobacterial, yeast, and fungal LATs, which are the
closest homologs to vertebrate LATs (up to 37% amino acid se-
quence identity) that do not interact with a heavy subunit (Table
S1). Hydrophobic NIP residues also are largely conserved in
b0,+AT (Table S1). Thus, desolvation of hydrophobic residues also
might contribute to the binding of the ectodomain of rBAT and its
light subunit. Indeed, cotransfection of 4F2hc and b0,+AT (i.e., the
rBAT-associated light subunit) in mammalian cells yielded func-
tional transporter at the cell surface (24). Interaction through
a hydrophobic patch seems like a clever way to glue 4F2hc to six
different light subunits (LAT1, LAT2, y+LAT1, y+LAT12, asc1,
and xCT) that share as little as ∼43% amino acid sequence
identity (1). Our work revealed that 4F2hc-ED covers the ex-
ternal face of LAT2, increasing transporter stability. The idea
that a common hydrophobic patch serves for subunit recognition
by 4F2hc merits future experimental examination.
Methods
The indicated tagged versions of human 4F2hc and LAT2 were expressed and
purified as reported previously (18). L-leucine transport by Pichia cells was
performed as described (18). Transport activity of LAT2, 4F2hc, and 4F2hc/
LAT2 was tested as described previously (13) by measuring their L-leucine/
L-isoleucine exchange activity in reconstituted proteoliposomes. TEM, SPA,
and 3D reconstruction were performed as described in SI Methods. Docking
calculations of 4F2hc-ED–LAT2 interaction were performed based on the
pyDock protocol (25), and the most relevant LAT2 residues for the in-
teraction with 4F2hc were identified by using the NIP value (26). To validate
the docking model, intersubunit crosslinking was performed in different
versions of purified 4F2hc/LAT2 heterodimer expressed in HEK cells. The
effect of 4F2hc-ED on the detergent solubilization and stability of human
LAT2 was tested by incubating Pichia membranes expressing LAT2 (18) with
purified 4F2hc-ED (8) before solubilization with DDM. Soluble LAT2 protein
was detected and quantified by Western blotting. See SI Methods for details.
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